Applied DNA Sciences signs joint development agreement with Everledger
Applied DNA Sciences announced the signing of a Joint Development Agreement with Everledger. Under the Agreement the parties will develop and market a combined physical and digital supply chain traceability and certification solution utilizing the company's CertainT molecular tagging and authentication systems together with Everledger's blockchain-based platform. The signing of the Agreement follows a Memorandum of Understanding, or MOU, announced on July 31, 2018. The parties believe this joint solution platform is at the forefront of linking immutable digital transactions with synthetic molecular authentication to tightly track movement and chain of custody of forensically-identified goods across complex ecosystems. Everledger's blockchain-based platform is proven to offer transparency and asset protection across various industries including diamonds, colored gemstones and jewelry, and is scaled for industry standardization as evidenced by the encrypted provenance of over 2.2 million diamonds. Applied DNA's CertainT platform has demonstrated its "tag and test" capability having captured millions of tagging data points and thousands of sample authentication reports.